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CC BY-NC-ND license (http://creativeAbstract This study aimed to investigate the protective effects of oridonin (ORI) on cecal
ligation and puncture (CLP)-induced sepsis in mice. Male C57BL/6 mice weighing 22e30 g
and aged 8e10 weeks were randomly assigned to three groups: Sham group, CLP group, or
CLP plus ORI group. In the CLP group and ORI group, CLP was induced, and intraperitoneal in-
jection of normal saline and oridonin (100 mg/kg) was conducted, respectively. The survival
rate was determined within the following 7 days. The blood, liver, and lung were collected
at 24 hours after injury. Hematoxylineeosin staining of the lung, detection of lung wet-to-
dry ratio, and serum cytokines (tumor necrosis factor [TNF]-a and interleukin [IL]-6), and ex-
amination of intraperitoneal and blood bacterial clearance were conducted to evaluate the
therapeutic efficacy. Results showed that ORI treatment significantly reduced the lung wet-
to-dry ratio, decreased serum TNF-a and IL-6, and improved liver pathology compared with
the CLP group (p < 0.05). Moreover, the intraperitoneal and blood bacterial clearance
increased markedly after ORI treatment (p < 0.05). The 7-day survival rate in the ORI group
was also dramatically higher than in the CLP group (p < 0.05). Our findings indicate that ORI
can attenuate liver and lung injuries and elevate bacterial clearance to increase the survival
rate of sepsis mice.
Copyright ª 2016, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).eclare no conflicts of interest.
t of Oncology, Shanghai Medical College, Fudan University, Number 270, Dong’an Road, Shanghai
com (Y. Zhu).
6.07.013
ng Medical University. Published by Elsevier Taiwan LLC. This is an open access article under the
commons.org/licenses/by-nc-nd/4.0/).
Oridonin protects mouse against sepsis 453Introduction
Sepsis is a syndrome, not a disease. It is an imprecise
clinical diagnostic term used to describe patients who have
a continuum of abnormalities in organ function [1]. The
worldwide incidence of sepsis is estimated to be 18 million
cases per year [2]. Sepsis remains the most common cause
of death in people who have been hospitalized, and be-
tween 20% and 50% of patients with sepsis die [3,4].
Furthermore, sepsis is associated with a reduced quality of
life in those who survive their acute illness [5].
Unlike other major epidemic illnesses, treatment for
sepsis is nonspecific and limited primarily to support organ
function and consists of administration of intravenous
fluids, antibiotics, and oxygen [6]. There are no approved
drugs that specifically target sepsis. In recent years,
increasing studies employ Traditional Chinese Medicine in
the therapy of sepsis [7e9]. Oridonin (ORI) is a famous
diterpenoid isolated from the Chinese medicinal herb
Rabdosia rubescens which is also known as dong ling cao
[10]. This compound has drawn attention for its remarkable
apoptosis and autophagy-inducing activity in cancer ther-
apy [11]. However, many prominent studies have proven
that ORI possesses many other therapeutic effects, such as
antiinflammatory, neuroprotective, antibacterial, and
antineoplastic activities [12e14]. In this study, the pro-
tective effects of ORI on sepsis were investigated in a
mouse model. Our results show that ORI treatment atten-
uates lung and liver injuries and enhances the survival rate
of sepsis mice, which is due to the reduction in serum
proinflammatory cytokines and increase in serum and
peritoneal bacterial clearance.Materials and methods
Animals and grouping
A total of 50 male C57BL/6 mice aged 8e10 weeks and
weighing 22e30 g were purchased from the Experimental
Animal Center of the Second Military Medical University.
Mice were randomly assigned into three groups. In the Sham
group (n Z 10), mice received laparotomy without manip-
ulation of the intestine; in the CLP group, mice received
cecal ligation and puncture (CLP) followed by intraperito-
neal injection of normal saline (nZ 10 for survival analysis;
n Z 10 for biochemical analysis); in the CLPþORI group,
mice received CLP followed by intraperitoneal injection of
ORI at 100 mg/kg (n Z 10 for survival analysis; n Z 10 for
biochemical analysis). Animals were housed under
controlled temperatures (23  2C) with 12 hours of light/
dark cycles and given ad libitum access to food and water.
This study was approved by the Ethics Committee of the
Second Military Medical University.
Reagents
The following reagents were used in the present study: ORI
(Lot number: 28957-04-2; Shanghai Yuanye Biotechnology
Co., Ltd. China), hematoxylineeosin staining kit (Wuhan
Boster Biotechnology Co., Ltd. China), nutrient agarmedium (Shanghai Tiancheng Biotechnology Co., Ltd.
China), paraformaldehyde (Sinopharm Biochemical Re-
agents Company, Shanghai, China), mouse tumor necrosis
factor-a (TNF-a), Quantikin Enzyme-Linked Immunosorbent
Assay (ELISA) Kit (Cat: MTA00B), and mouse interleukin-6
(IL-6) Quantikin ELISA Kit (Cat:M6000B; R&D Systems Inc.,
MN, USA).
Animal model of sepsis
CLP was employed to induce sepsis in mice. Briefly,
following isoflurane anesthesia, the cecum was exposed
after a 1-cm-long midline incision was made. The cecum
was ligated w15 mm proximal to the cecal pole with a 5/
0 Prolene thread without stricture of the ileocecal valve.
The ligated cecum was then punctured once with a 22-
gauge needle. The cecum was slightly compressed until a
small drop of stool appeared. The abdominal wall was
closed, and fluid resuscitation was conducted with subcu-
taneous injection of 1 mL of normal saline after surgery. In
the CLP group, mice received intraperitoneal injection of
normal saline immediately after surgery; in the CLPþORI
group, mice received intraperitoneal injection of oridonin
at 100 mg/kg immediately after surgery.
Detection of serum cytokines
At 24 hours after surgery, mice were deeply anesthetized
with 10% chloral hydrate at 0.3 mL/100 g and sacrificed.
Blood was collected from the heart, and serum was
collected after centrifugation. Serum contents of TNF-a
and IL-6 were detected with corresponding ELISA kits ac-
cording to the manufacturer’s instructions.
Pathological examination
At 24 hours after surgery, mice were anesthetized, and the
liver and lung were collected, fixed in 4% para-
formaldehyde, and embedded in paraffin and sectioned.
Hematoxylineeosin staining was performed to evaluate the
liver and lung injuries.
Detection of lung wet-to-dry lung weight ratio
At 24 hours after surgery, animals were sacrificed and the
left lungs were collected and weighed after removing water
on the lung (wet weight). The lung was then heated at 60C
for 72 hours until the lung weight remained stable. The lung
was weighed (dry weight). The wet to dry (W/D) weight
ratio was calculated.
Detection of bacterial clearance
At 24 hours after CLP, mice were anesthetized with 2.5%
isoflurane. Mice were fixed on a table and anesthesia was
maintained with 2.5% isoflurane. The skin of the abdomen
was cut open (0.5 cm) in the midline after thorough disin-
fection. Blood (200 mL) was collected by sterile puncture of
the left cardiac ventricle with a syringe, transferred into a
sterile tube and stored at 4C. Then, laparotomy was
454 Y.-J. Zhao et al.performed and the peritoneal cavity was exposed. Sterile
1 phosphate buffer solution (Sinopharm Co., Ltd, China)
(2 mL) was injected into and aspirated out of the peritoneal
cavity five times. The peritoneal lavage fluid (PLF) was
stored at 4C. Bacteria were grown, and identification tests
were conducted in accordance with routine bacteriological
methods. Bacterial counts are given as number of milliliter
of peritoneal lavage or blood.
Survival rate
The survival status was observed within 7 days, and the
survival rate was calculated, followed by delineation of
survival curve.
Statistical analysis
Statistical analysis was performed with GraphPad Prism 5
(GraphPad Software, Inc., San Diego, CA, USA). Quantita-
tive data are expressed as mean  standard deviation.
Significant differences among groups were assessed with
one way analysis of variance, followed by Stu-
denteNewmaneKeuls-q test. The survival was analyzed
with KaplaneMeier survival curves and log-rank test. A p
value < 0.05 was considered statistically significant.
Results
Survival analysis
Survival curves were analyzed in three groups. None died in
the Sham group. The survival rate was 20% in the CLP group
and 70% in the CLPþORI group at 7 days after surgery,
showing a significant difference between them (Figure 1).
This suggests that postoperative oridonin treatment im-
proves the survival of CLP mice.
Microscopic analysis
In the Sham group, the liver structure was nearly normal
and there were no hepatocyte necrosis, no hemorrhage,Figure 1. Seven-day survival rate in three groups. The sur-
vival rate was 20% in the cecal ligation and puncture (CLP)
group and 70% in the CLPþoridonin (ORI) group at 7 days after
surgery. The survival rate in the CLP group was significantly
lower than in the CLPþORI group.and no infiltration of inflammatory cells. In the CLP group,
severe hepatocyte swelling was present, the hepatic cord
was irregularly arranged, and the hepatic sinus was com-
pressed and narrowed. After ORI treatment, the liver injury
was significantly attenuated: the hepatocytes were nearly
normal, hepatocyte swelling was alleviated, and hepatic
sinus compression was mitigated (Figure 2). In the Sham
group, the lung structure was intact: no alveolar hemor-
rhage, normal alveolar septum, normal pulmonary capil-
laries, and no inflammatory cells. In the CLP group, the lung
structure was significantly disrupted, and alveolar hemor-
rhage, pulmonary interstitial edema, alveolar collapse, and
infiltration of a large amount of inflammatory cells were
observed in the lung. After ORI treatment, the lung injury
was markedly attenuated: alveolar septum was widened
slightly, there was no obvious alveolar hemorrhage, and
only a few inflammatory cells infiltrated in the lung
(Figure 2).
Lung W/D ratio
In the sham group, the lung W/D ratio was 3.85  0.28. At
24 hours after CLP, the lung W/D ratio was 4.23  0.19,
which was significantly higher than in the Sham group
(p < 0.05). However, ORI treatment dramatically attenu-
ated lung edema, characterized by a reduction in lung W/D
ratio (3.99  0.15, p < 0.05 vs. CLP group; Figure 3).
Serum contents of TNF-a and IL-6
The serum contents of TNF-a and IL-6 were 5.8  5.4 pg/mL
and 50.2  11.2 pg/mL in the Sham group. At 24 hours after
CLP, the serum contents of TNF-a and IL-6 increased
markedly (49.8  17.1 pg/mL and 539  133.7 pg/mL,
respectively, p < 0.05). However, ORI treatment after CLP
significantly reduced the serum TNF-a and IL-6 contents
(22.5  4.1 pg/mL and 240.8  67.1 pg/mL, respectively,
p < 0.05 vs. CLP group; Figure 4).
Blood and peritoneal bacterial clearance
Bacterial culture showed there were no bacteria in both
blood and PLF in the sham group. At 24 hours after CLP,
results showed the bacterial counts of the blood and PLF
increased remarkably (71.7  25.4 and 6.9  1.0  104,
respectively, p < 0.05 vs. sham group). However, ORI
treatment after CLP significantly reduced the bacterial
counts of the blood and PLF (15.3  7.5 and
0.14  0.07  104, respectively, p < 0.05 vs. CLP group;
Figure 5).
Discussion
Sepsis remains a major cause of morbidity and mortality in
hospitalized patients. Although numerous studies have
been conducted to investigate the pathogenesis and ther-
apy of sepsis, treatment for sepsis is still nonspecific and
there are no approved drugs that specifically target sepsis
[6]. In recent years, Traditional Chinese Medicine is
employed for the prevention and therapy of sepsis. In this
Figure 2. Liver and lung morphology in different groups. In the Sham group, the liver structure was nearly normal. In the cecal
ligation and puncture (CLP) group, severe hepatocyte swelling, irregularly arranged hepatic cord, and compressed and narrowed
hepatic sinus were observed. After oridonin (ORI) treatment, the morphology of hepatocytes was nearly normal, hepatocyte
swelling was alleviated, and hepatic sinus compression was mitigated. In the Sham group, the lung structure was complete. In the
CLP group, the lung structure was significantly disrupted, and alveolar hemorrhage, pulmonary interstitial edema, alveolar
collapse, and infiltration of a large amount of inflammatory cells were observed. After ORI treatment, the alveolar septum was
widened slightly, there was no obvious alveolar hemorrhage and only a few inflammatory cells infiltrated in the lung. Scale bar:
50 mm.
Figure 3. Lung wet-to-dry (W/D) ratio in different groups.
The lung W/D ratio was 3.85  0.28 in the Sham group,
4.23  0.19 in the cecal ligation and puncture (CLP) group and
3.99  0.15 in the CLPþoridonin (ORI) group. ORI treatment
dramatically reduced lung W/D ratio in mice after CLP.
* p < 0.05 versus Sham group. ** p < 0.05 versus CLP group.
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sepsis in a mouse model. Our results showed that ORI
significantly reduced the lung W/D ratio, decreased serum
proinflammatory cytokines and improved liver and lung
pathology, as well as increased the intraperitoneal and
blood bacterial clearance and 7-day survival rate.
ORI is a famous diterpenoid isolated from the Chinese
medicinal herb R. rubescens [10]. Increasing studies have
been conducted to investigate the biological activities ofORI and its protective effects in many disease models [15].
In recent years, increasing attention has been paid to its
antineoplastic activity [11] although studies have reported
its antiproliferative, neuroprotective, antibacterial, and
antiinflammatory effects as well as effects on the immune
system [12e14,16]. In this study, we investigated the pro-
tective effects of ORI on sepsis in a mouse model.
Sepsis is more properly defined as “a failure of homeo-
stasis,” i.e., “an inability for the organism or cell to
maintain internal equilibrium by adjusting its physiological
processes under fluctuating environmental conditions in
response to infection or injury” [3]. Inflammation and im-
mune dysfunction are closely related to the pathogenesis of
sepsis. Events developing early in sepsis suggest that a
hyperinflammatory state exists, and development of
immunosuppression and degraded innate and adaptive im-
mune responses are well-established complications of
sepsis. Studies have revealed a marked suppression of cell-
mediated immunity that appears to contribute to the
morbidity and mortality in sepsis [17] and there is a shift
from a Th1 to a Th2 response as well as the induction of an
immune suppressive macrophage phenotype in sepsis [18].
Thus, investigators have attempted to treat sepsis with
immunomodulatory strategies in clinical practice [19]. The
immune dysfunction may induce the hyperinflammatory
response, resulting in the production of proinflammatory
cytokines (cytokine storm) [20]. Hu et al [16] found that ORI
had a distinct effect on promoting CD4þ/CD25þ Treg dif-
ferentiation and modulating Th1/Th2 balance, which was
achieved via inducing the antiinflammatory target HO-1. Ku
Figure 4. Serum contents of tumor necrosis factor (TNF)-a and interleukin-6 (IL-6) in different groups. The serum contents of
TNF-a and IL-6 were 5.8  5.4 pg/mL and 50.2  11.2 pg/mL, respectively, in the Sham group, 49.8  17.1 pg/mL and
539  133.7 pg/mL, respectively, in the cecal ligation and puncture (CLP) group, and 22.5  4.1 pg/mL and 240.8  67.1 pg/mL,
respectively, in the CLPþoridonin (ORI) group. ORI treatment significantly reduced the serum contents of TNF-a and IL-6. * p < 0.05
versus Sham group. ** p < 0.05 versus CLP group.
Figure 5. Bacterial counts in different groups. The bacterial counts of the blood and peritoneal fluid increased significantly in
the cecal ligation and puncture (CLP) group compared with the Sham group. However, oridonin (ORI) treatment significantly
reduced the bacterial counts of the blood and peritoneal fluid. * p < 0.05 versus Sham group. **p < 0.05 versus CLP group.
CFU Z colony forming units; PLF Z peritoneal lavage fluid.
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inclination property. There is evidence showing that ORI is
able to inhibit the secretion of IL-2, interferon-g, IL-12p40,
and TNF-a in murine splenic lymphocytes [22]. However,
ORI may also facilitate phagocytic activity against
apoptotic cells through TNF-a and IL-1b release, thereby
contributing to its antitumor activity [23]. Our results also
showed that ORI was effective to reduce serum proin-
flammatory cytokines, and also increased the blood and
peritoneal bacterial clearance in sepsis mice.
Of note, ORI does not easily dissolve in water, and thus
its blood concentration cannot easily match its need. To
overcome this, some groups have prepared ORI nano-
suspension and nanoparticles [24,25] as well as ORI analogs
[26].
There were still limitations in this study. The dose-
response curve of ORI was not investigated in our study, and
thus we can not confirm the optimal dose of ORI for the
treatment of sepsis. In our pilot study, sepsis mice were
initially treated with ORI at 10 mg/kg which is the most
common dose used in available studies [27]. However, thealanine aminotransferase further increased in sepsis mice
after ORI treatment. Then, the dose was reduced, and ORI
at 100 mg/kg and 1 mg/kg was used. The alanine amino-
transferase slightly increased after treatment with ORI at
1 mg/kg in sepsis mice. Considering that there is pre-
existing liver injury in sepsis, ORI at 100 mg/kg was used
in this study. In addition, only short-term treatment with
ORI was performed in mice. Whether long-term ORI treat-
ment has a better therapeutic efficacy and whether
repeated treatment with ORI increases the risk for adverse
effects in case of sepsis are still unclear. Moreover, the
specific mechanism underlying the therapeutic effects of
ORI was not further studied. Studies have identified several
proteins targeted by ORI and transcription factors and
signaling pathways regulated by ORI [15]. Thus, more
studies with elegant design are required to elucidate the
potential mechanisms underlying the protective effects of
ORI on sepsis.
Taken together, our results indicate that ORI reduces
proinflammatory cytokines and increase blood and perito-
neal bacterial clearance to exert protective effects on
Oridonin protects mouse against sepsis 457sepsis in mice. More studies are required to investigate the
optimal dose of ORI in the treatment of sepsis, explore the
specific mechanism underlying its protective effects on
sepsis, and improve the bioavailability and safety of ORI in
the therapy of diseases.References
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